Ms. Rehnuma Tasmiyah Chowdhury | Natural Drugs | Innovative Research Award
Bangladesh Council of Scientific and Industrial Research | Bangladesh
100
80
60
40
20
0
Documents
h-index
View Scopus Profile
View Orcid Profile
Bangladesh Council of Scientific and Industrial Research | Bangladesh
100
80
60
40
20
0
View Scopus Profile
View Orcid Profile
Joanneum Research | Austria
Dr. Thomas Birngruber is a leading researcher with a distinguished record in pharmacokinetics, pharmacodynamics, and translational drug delivery research. His expertise spans dermatology, neurology, and subcutaneous drug application, including inflammatory skin diseases, biomarker identification, blood-brain barrier transport, and neuroactive nanoparticle formulations. He has authored 55 publications, accumulating 1,043 citations by 845 documents, and holds an h-index of 17. Dr. Birngruber has pioneered methodologies such as open flow microperfusion for skin and brain, ex vivo human skin models, and targeted nanoliposomes, bridging fundamental research with clinical and commercial drug development.
1200
1000
800
600
400
200
0
View Scopus Profile
View Orcid Profile

Assefa Kebad Mengesha has over 10 years of academic and research experience at the University of Gondar, Ethiopia. As a lecturer in the Department of Pharmacology, he has been instrumental in teaching undergraduate and graduate students, focusing on health-related pharmacology and education. He has mentored numerous students, guiding them through research projects and helping them achieve academic success. Assefa has also contributed to curriculum development, ensuring that teaching materials align with current research trends and industry needs. His experience includes conducting pharmacological research that has led to 13 publications in reputable indexed journals. Beyond his teaching and research roles, Assefa has participated in various academic committees, fostering collaboration and innovation within his institution. His extensive experience underscores his commitment to education, research excellence, and the advancement of pharmacology as a discipline.
Although there are no specific awards or honors listed in his current profile, Assefa Kebad Mengesha’s contributions to pharmacological research and education reflect a career deserving of recognition. His 13 published articles in reputable journals indexed in Scopus and PubMed signify his academic commitment and scholarly excellence. Additionally, his role in mentoring students and developing innovative curricula at the University of Gondar highlights his dedication to advancing education. Assefa’s decade-long experience in pharmacology education and research positions him as a valuable asset to his academic community. Future awards and honors would further validate his contributions and solidify his standing as a respected educator and researcher. He remains focused on expanding his impact through continued research and professional development.
Assefa Kebad Mengesha’s research focuses on health-related pharmacology and education, addressing critical challenges in medical sciences. His primary interest lies in investigating pharmacological mechanisms and interventions for managing health disorders. By integrating innovative methodologies and evidence-based approaches, his research aims to enhance the understanding and treatment of health-related issues. Assefa has also explored educational strategies in pharmacology, emphasizing the integration of research findings into teaching practices to foster a robust learning environment for students. Over the years, his work has resulted in 13 publications in reputable indexed journals, contributing to the global body of knowledge in pharmacology. His interdisciplinary approach, combining pharmacology and education, reflects his commitment to improving healthcare outcomes and advancing medical education. Assefa’s research aligns with his broader goal of bridging the gap between theoretical pharmacology and its practical application in healthcare settings.

Dr. Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University, Poznań, where she specialized in molecular biology, conducting research on modified DNA bases. She earned her Ph.D. from the Medical University of Poznań and Adam Mickiewicz University, focusing on genetic polymorphisms related to osteoporosis risk. Her doctoral work on estrogen and calcitonin receptors laid the foundation for her expertise in pharmacogenetics.
Dr. Bartkowiak-Wieczorek is currently an Assistant Professor and research staff member at the Medical University of Karol Marcinkowski in Poznań, where she has been teaching and conducting research since 2018. Previously, she worked at the Medical University of Poznań, focusing on pharmacogenetics research and quality management in drug development. She also contributed to the Institute of Natural Fibres and Medicinal Plants, Poznań, implementing ISO and GMP standards, which supports her commitment to rigorous quality in research and clinical practices.
Dr. Bartkowiak-Wieczorek is skilled in pharmacogenetic analysis, biochemistry, and molecular biology techniques, including DNA isolation, PCR, and ELISA. She has a strong foundation in quality management, having implemented GMP, ISO 9001, and ISO 17025 standards in clinical and preclinical studies. Her expertise also extends to pharmacogenetic testing, pharmacotherapy, and plant-based compound analysis, notably with cannabinoids.
Dr. Bartkowiak-Wieczorek is skilled in pharmacogenetic analysis, biochemistry, and molecular biology techniques, including DNA isolation, PCR, and ELISA. She has a strong foundation in quality management, having implemented GMP, ISO 9001, and ISO 17025 standards in clinical and preclinical studies. Her expertise also extends to pharmacogenetic testing, pharmacotherapy, and plant-based compound analysis, notably with cannabinoids.
Dr. Bartkowiak-Wieczorek is actively involved in several scientific communities, contributing her knowledge in biochemistry, pharmacology, and personalized medicine. Her collaborative work with institutions such as the National Science Centre and participation in interdisciplinary research projects demonstrate her dedication to advancing pharmacogenetics and biopharmacy.
She has extensive teaching experience, instructing students in various programs, including Medicine, Pharmacy, and Dentistry, at the Medical University of Karol Marcinkowski. Her courses cover human physiology, pharmacology, pharmacogenetics, and quality management, reflecting her comprehensive approach to teaching future medical professionals.
Dr. Bartkowiak-Wieczorek’s research centers on pharmacogenetics, particularly the interaction of genetics with drug efficacy and safety. She explores plant-based compounds, with a specific focus on cannabinoids and their applications in oncology and chronic disease management. Her research projects include studies on gene expression, drug interactions, and the pharmacokinetics of pediatric treatments, which contribute to the field of personalized medicine.

Joanna Bartkowiak-Wieczorek holds a Master of Science in Biological Sciences from Adam Mickiewicz University in Poznań, specializing in molecular biology. She completed her PhD at the Medical University of Poznań, focusing on epigenetic modifications in hybrids of green frogs and the polymorphism of genes associated with osteoporosis risk.
Since September 2018, she has served as an Assistant Professor at the Medical University of Karol Marcinkowski in Poznań, where she conducts research and teaches various programs in human physiology. Prior to this, she worked as scientific and technical staff at the Medical University of Poznań, conducting pharmacogenetic research and educational classes. She also held roles focused on quality management systems at the Institute of Natural Fibres and Medicinal Plants, contributing to the implementation of GMP and ISO standards.